Epigenetic Mechanisms Involved in Hcv Infection and Human HCC

Area of Science:

• Epigenetics
• Hepatology
• Virology
• Oncology

Background:

• Hepatitis C virus (HCV) infection is a significant global health issue, frequently leading to chronic liver disease and hepatocellular carcinoma (HCC).
• Epigenetic regulation by non-coding RNAs (ncRNAs) is increasingly recognized for its critical role in viral pathogenesis and cancer development.
• Understanding the complex interplay of ncRNAs in HCV infection is vital for developing effective treatments.

Purpose of the Study:

• To provide an integrated overview of the functions of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in HCV-induced liver injury.
• To highlight the dual roles of these ncRNAs in viral replication and tumor suppression.
• To discuss the potential of ncRNAs as diagnostic biomarkers and therapeutic targets for HCV-associated HCC.

Main Methods:

• Literature review synthesizing current research on ncRNAs in HCV infection and HCC.
• Analysis of the functional roles of miRNAs, lncRNAs, and circRNAs in viral pathogenesis.
• Examination of ncRNA interaction networks, including molecular sponge mechanisms, and their impact on hepatic homeostasis.

Main Results:

• ncRNAs exhibit dual roles in HCV infection, with some promoting viral replication and others acting as tumor suppressors.
• Dysregulation of ncRNAs, including lncRNAs and circRNAs acting as miRNA sponges, disrupts hepatic homeostasis and promotes inflammation and tumorigenesis.
• Specific ncRNA signatures are associated with HCV infection and HCC development.

Conclusions:

• ncRNAs are key epigenetic regulators in HCV pathogenesis and hepatocarcinogenesis.
• ncRNA interaction networks are critical for maintaining liver health and are disrupted during HCV infection.
• ncRNAs represent promising diagnostic biomarkers and therapeutic targets for managing HCV-associated liver disease and HCC.